Moody Aldrich Partners LLC Invitae Corp Transaction History

Moody Aldrich Partners LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$14.7 - $28.67 $2.64 Million - $5.16 Million	-179,891 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$24.31 - $33.6 $619,248 - $855,892	25,473 Added 16.5%	179,891 $5.11 Million
Q2 2021 Aug 04, 2021	SELL	$26.09 - $40.4 $51,579 - $79,870	-1,977 Reduced 1.26%	154,418 $5.21 Million
Q1 2021 May 10, 2021	BUY	$33.06 - $56.93 $88,171 - $151,832	2,667 Added 1.73%	156,395 $5.98 Million
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $4,299 - $6,314	-110 Reduced 0.07%	153,728 $6.43 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $118,666 - $186,452	4,174 Added 2.79%	153,838 $6.67 Million
Q2 2020 Jul 30, 2020	BUY	$11.71 - $30.29 $255,008 - $659,625	21,777 Added 17.03%	149,664 $4.53 Million
Q1 2020 May 07, 2020	BUY	$7.64 - $27.5 $291,496 - $1.05 Million	38,154 Added 42.52%	127,887 $1.75 Million
Q4 2019 Feb 07, 2020	BUY	$15.02 - $20.57 $301,962 - $413,539	20,104 Added 28.87%	89,733 $1.45 Million
Q3 2019 Nov 12, 2019	BUY	$18.85 - $27.5 $1.31 Million - $1.91 Million	69,629 New	69,629 $1.34 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.